产品名称 编号 产品说明 单位 单价 加入购物车
Protein A/G磁珠 22204-1 1 mL, 10 mg/mL, 2 μm ¥285.00
Protein A/G磁珠 22204-5 5 mL, 10 mg/mL, 2 μm ¥1295.00
Protein A/G 免疫沉淀试剂盒 22202-20 20次反应 ¥680.00
Protein A/G 免疫沉淀试剂盒 22202-100 100次反应 ¥1980.00
Protein A 免疫沉淀试剂盒 22203-20 20次反应 ¥680.00
Protein A 免疫沉淀试剂盒 22203-100 100次反应 ¥1980.00

BeaverBeads™ Protein A/G 免疫沉淀磁珠试剂盒系列产品是利用海狸生物纳米表面技术,使Protein A/G 高密度定向包 被到超顺磁性微球表面,与当前国际免疫磁珠市场上同类产品相比,该产品具有更多的抗体结合位点,磁珠使用量 更少,非特异性结合率低,可便捷高效地进行免疫沉淀实验。每毫升免疫沉淀磁珠结合Human lgG的能力可达到 300μg以上,单个沉淀反应仅需50μg磁珠即可完成检测。纳米级磁珠提供的超大比表面积,大幅缩短抗体与抗原吸附 所需的平衡时间,10分钟内即可完成抗体吸附过程,30分钟内完成抗原沉淀操作。简短的操作时间避免长时间操作 造成目标蛋白被水解,保证了目标蛋白的活性及蛋白复合物的完整性。 免疫沉淀磁珠试剂盒配有经过优化的预制缓冲液,为免疫沉淀实验提供了最佳的反应条件,提高了免疫沉淀实验的 稳定性。 本产品可广泛应用于细胞裂解物、细胞分泌上清、血清、腹水等样品中抗原的免疫沉淀反应。


产品特点

• 高效率、高产量、低消耗

• 操作灵活、简便

• 实验结果可靠、重复性高

• 非特异性吸附低

应用实例

BeaverBeads™  ProteinA/G与同类产品进行免疫沉淀实验结果对比。

BeaverBeads™ Protein A/G与同类产品采用多克隆、单克隆抗体进行免疫沉淀实验结果对比。

BeaverBeads™ 免疫沉淀磁珠试剂盒成功纯化富集目标蛋白GST-Tag 的实验结果。


引用文献:


  1. MTFR2‐Mediated Fission Drives Fatty Acid and Mitochondrial Co‐Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis.Advanced Science,2025(IF:14.1)

  2. DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization.Theranostics,2025,(IF:13.3)

  3. BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon Signaling through Stabilizing STING.Advanced science news,2025(IF:13.3)

  4. FBXW7/GSK3β-mediated proline-rich 11 degradation promotes oxidative DNA damage and inhibits tumor progression in renal cell carcinoma.Theranostics,2025(IF:13.3)

  5. Mechanism-guided rational design of anti-neuroinflammatory keratin-derived protein for spinal cord injury repair.Cell Biomaterials.2025(IF:12.8)

  6. CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis.Journal of Experimental & Clinical Cancer Research.,2025(IF:11.16)

  7. Excision Repair Cross Complementation Group 1 gene exon 3 skip** isoform presents selective cGAS-STING activation in Platinum-sensitive lung adenocarcinoma.Free Radical Biology and Medicine.2025(IF:8.2)

  8. Cutin formation in tomato is controlled by a multipartite module of synergistic and antagonistic transcription factors.Cell Reports.2025,(IF:6.9)

  9. Liu J, Luo Y, Chen S, et al. Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT[J]. Advanced Science, 2024, 11(45): 2403995.(IF:14.3)

  10. Lu J, Li N, Li G, et al. N-glycosylation of SnRK2s affects NADPH maintenance in peroxisomes during prolonged ABA signalling[J]. Nature Communications, 2024, 15(1): 6630.(IF:14.7)

  11. Fu W, Lin Y, Bai M, et al. Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing[J]. Acta Pharmaceutica Sinica B, 2024, 14(9): 3931-3948.(IF:14.7)

  12. Li X, Chen X, Yang F, et al. Effect of mitochondrial translocator protein TSPO on LPS-induced cardiac dysfunction[J]. Journal of Advanced Research, 2024.(IF:11.4)

  13. Protective effect of hydrogen sulfide on TNF-a and IFN-c-induced injury of intestinal epithelial barrier function in Caco-2 monolayers;Pharmacological research    出版年: 2016-Nov-10 (Epub 2016 Nov 10)

  14. 树鼩IgG纯化鉴定及其多克隆抗体制备和检测; 现代生物医学进展

  15. 血管性血友病因子裂解酶(ADAMTS13)单克隆抗体的鉴定以及生物学功能的研究;中国实验血液学杂志

  16. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity;Oncogene (2017) 36, 6391–6407,DOI:10.1038/onc.2017.241



    暂无视频